Target intelligence / Profile preview

novel transcript, antisense to HACD2

Molecular classification
Other, long non-coding RNA, antisense RNA
01

Overview

This gene (ENSG00000298604) is annotated by Ensembl as a novel transcript that is antisense to the protein-coding HACD2 gene[1][3][5]. There is no evidence that ENSG00000298604 encodes a protein, receptor, or other canonical drug target molecule. It is cataloged as a long non-coding RNA (lncRNA), typically considered to have regulatory—but not directly druggable—functions. There are no known aliases beyond its database identifiers, and there are no associated molecular functions, disease roles, or interactions with drugs documented in current resources. As such, it is not considered a validated or conventional therapeutic target, and the information available is too limited for further classification. Note: The request is affected by the non-specific nature of this target: ENSG00000298604 is not a confirmed receptor, enzyme, or drug target; it is *likely a non-coding RNA* whose function, role in disease, and potential as a therapeutic target are uncharacterized or unknown[5]. If your goal is to retrieve information on the adjacent protein-coding gene (HACD2; 3-hydroxyacyl-CoA dehydratase 2), which is functionally relevant in mitochondrial lipid metabolism and disease, please specify—HACD2 is a well-established enzyme and potential target, while ENSG00000298604 is likely nonfunctional in the conventional sense and not a direct therapeutic target[11].

Other names
ENSG00000298604novel transcript, antisense to HACD2

Beyond the preview

Go deeper on novel transcript, antisense to HACD2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to HACD2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call